Abstract
Paget’s disease of bone (PDB) has become less common over recent decades but it is unclear if this has impacted on clinical presentation. Here we evaluated the presenting features of PDB in a contemporary cohort of UK patients and conducted a systematic review of studies in which the presenting features had been reported. The case series comprised 88 patients referred to a specialist clinic between 2005 and 2013. Bone pain was the most common presenting feature occurring in 73.8 % of patients. Others included bone deformity (18.1 %), deafness (7.9 %) and pathological fracture (5.7 %). The disease was asymptomatic in 22 % of cases. Antiresorptive treatment was given for pain in 34 cases and 61.7 % of patients responded. Patients with a shorter disease duration were more likely to respond (p = 0.047). In the systematic review, bone pain was the most common presenting feature (52.2 % of cases) followed by deformity (21.5 %), deafness (8.9 %) and fracture (8.5 %). Time trend analysis in subjects of European descent showed that fracture was less common in studies performed during the past 25 years as compared with older studies (5.5 vs. 10.8 % p < 0.001) whereas pain was more common (54.3 vs. 48.3 %, p = 0.003). While changes in the mode of presentation of PDB have occurred over recent years, many patients present with complications such as fracture and deformity. Further research is required to determine if early detection and therapeutic intervention might be of value in preventing the morbidity associated with this common disease.
Similar content being viewed by others
References
Ralston SH (2013) Clinical practice. Paget’s disease of bone. N Engl J Med 368:644–650
van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471
Poor G, Donath J, Fornet B, Cooper C (2006) Epidemiology of Paget’s disease in Europe: the prevalence is decreasing. J Bone Miner Res 21:1545–1549
Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T (2004) Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 75:358–364
Rendina D, de Gennari L, Filippo G, Merlotti D, de Campora E, Fazioli F, Scarano G, Nuti R, Strazzullo P, Mossetti G (2006) Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy. J Bone Miner Res 21:1828–1835
Corral-Gudino L, Garcia-Aparicio J, Sanchez-Gonzalez MD, Miron-Canelo JA, Blanco JF, Ralston SH, Del Pino-Montes J (2013) Secular changes in Paget’s disease: contrasting changes in the number of new referrals and in disease severity in two neighboring regions of Spain. Osteoporos Int 24:443–450
Corral-Gudino L, Borao-Cengotita-Bengoa M, Del Pino-Montes J, Ralston SH (2013) Epidemiology of Paget’s disease of bone: a systematic review and meta-analysis of secular changes. Bone 55:347–352
Selby PL, Davie MW, Ralston SH, Stone MD (2002) Guidelines on the management of Paget’s disease of bone. Bone 31:366–373
Visconti MR, Langston AL, Alonso N, Goodman K, Selby PL, Fraser WD, Ralston SH (2010) Mutations of SQSTM1 are associated with severity and clinical outcome in Paget’s disease of bone. J Bone Miner Res 25:2368–2373
Dhanwal DK, Siwach R, Dixit V, Mithal A, Jameson K, Cooper C (2013) Incidence of hip fracture in Rohtak district North India. Arch Osteoporos 8:135
Dhanwal DK, Cooper C, Dennison EM (2010) Geographic variation in osteoporotic hip fracture incidence: the growing importance of asian influences in coming decades. J. Osteoporos. 2010:757102
Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jonsson B, Kanis JA (2013) Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos 8:137
Lesnyak O, Ershova O, Belova K, Gladkova E, Sinitsina O, Ganert O, Romanova M, Khodirev V, JOhansson H, McCloskey E, Kanis JA (2012) Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos 7:67–73
Morales-Torres J, Gutierrez-Urena S (2004) The burden of osteoporosis in Latin America. Osteoporos Int 15:625–632
Altman RD (1980) Musculoskeletal manifestations of Paget’s disease of bone. Arthritis Rheum 23:1121–1127
Del Pino-Montes J, de Garcia Yebenes Prous MA, Torrijos Eslava A, Morales Piga A, Carbonell Abello J, Farrerons Minguela J, Garrido Garcia J, Gobbo Montoya M, Rodriguez Perez M, Tornero Molina J, Guanabens Gay N, Carmona L (2009) [Characteristics of Paget’s disease in Spain. Data from the National Paget’s Register]. Reumatol Clin 5:109–114
de Werner Castro GR, Heiden GI, Zimmermann AF, Morato EF, Neves FS, Toscano MA, de Magalhaes Souza Fialho SC, Pereira IA (2012) Paget’s disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget’s disease of bone in South America. Rheumatol Int 32:627–631
Gu JM, Zhang ZL, Zhang H, Hu WW, Wang C, Yue H, Ke YH, He JW, Hu YQ, Li M, Liu YJ, Fu WZ (2012) Thirteen Chinese patients with sporadic Paget’s disease of bone: clinical features, SQSTM1 mutation identification, and functional analysis. J Bone Miner Metab 30:525–533
Sankaran S, Naot D, Grey A, Cundy T (2012) Paget’s disease in patients of Asian descent in New Zealand. J Bone Miner Res 27:223–226
Varenna M, Zucchi F, Galli L, Manara M, De Marco G, Sinigaglia L (2010) Demographic and clinical features related to a symptomatic onset of Paget’s disease of bone. J Rheumatol 37:155–160
Bandeira F, Assuncao V, Diniz ET, Lucena CS, Griz L (2010) Characteristics of Paget’s disease of bone in the city of Recife, Brazil. Rheumatol Int 30:1055–1061
Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ III (2008) Morbidity and mortality associated with Paget’s disease of bone: a population-based study. J Bone Miner Res 23:819–825
Hashimoto J, Ohno I, Nakatsuka K, Yoshimura N, Takata S, Zamma M, Yabe H, Abe S, Terada M, Yoh K, Fukunaga M, Cooper C, Morii H, Yoshikawa H (2006) Prevalence and clinical features of Paget’s disease of bone in Japan. J Bone Miner Metab 24:186–190
Anjali Thomas, N, Rajaratnam S, Shanthly N, Oommen R, Seshadri MS (2006) Paget’s disease of bone: experience from a centre in southern India. J Assoc Physicians India 54:525–529
Bhadada S, Bhansali A, Unnikrishnan AG, Khadgawat R, Singh SK, Mithal A, Saikia UN (2006) Does Paget’s disease exist in India?: a series of 21 patients. J Assoc Physicians India 54:530–534
Joshi SR, Ambhore S, Butala N, Patwardhan M, Kulkarni M, Pai B, Karne R (2006) Paget’s disease from Western India. J Assoc Physicians India 54:535–538
Holgado S, Rotes D, Guma M, Monfort J, Olive A, Carbonell J, Tena X (2005) Paget’s disease of bone in early adult life. Ann Rheum Dis 64:306–308
Merlotti D, Gennari L, Galli B, Martini G, Calabro A, de Paola V, Ceccarelli E, Nardi P, Avanzati A, Nuti R (2005) Characteristics and familial aggregation of Paget’s disease of bone in Italy. J Bone Miner Res 20:1356–1364
Gonzalez G, Brusco F, Arteaga L, Rodriguez J, Jacobelli S, Massardo L, Ortiz C, Contreras O (2003) Paget disease of bone in Chile: report of 15 cases. Rev Med Chil 131:491–497
Guma M, Rotes D, Holgado S, Monfort J, Olive A, Carbonell J, Tena X (2002) Paget’s disease of bone: study of 314 patients. Med Clin (Barc) 119:537–540
Wang LM, Au-Yeong ML, McKenna MJ (2002) Paget’s disease of bone: presentation, extent and response to bisphosphonates. Ir Med J 95(244):246
Davie M, Davies M, Francis R, Fraser W, Hosking D, Tansley R (1999) Paget’s disease of bone: a review of 889 patients. Bone 24:11S–12S
Monfort J, Sala DR, Romero AB, Duro JC, Maymo J, Carbonell J (1999) Epidemiological, clinical, biochemical, and imaging characteristics of monostotic and polyostotic Paget’s disease. Bone 24:13S–14S
Hamdy RC, Moore S, Leroy J (1993) Clinical presentation of Paget’s disease of the bone in older patients. South Med J 86:1097–1100
Winfield J, Stamp TC (1984) Bone and joint symptoms in Paget’s disease. Ann Rheum Dis 43:769–773
Galbraith HJB, Evans EC, Lacey J (1977) Paget’s disease of bone: a clinical and genetic study. Postgrad Med J 53:33–39
Klimova MK (1958) Osteitis deformans-Paget’s disease analysis of clinical and X-ray studies on 238 subjects. Vestn Rentgenol Radiol 33:29–36
Russell RG, Smith R, Preston C, Walton RJ, Woods CG (1974) Diphosphonates in Paget’s disease. Lancet 1:894–898
Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA Jr, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ (1996) Biochemical and radiologic improvement in Paget’s disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med 101:341–348
Langston AL, Campbell MK, Fraser WD, MacLennan GS, Selby PL, Ralston SH (2010) Randomised trial of intensive bisphosphonate treatment versus symptomatic management in Paget’s disease of bone. J Bone Miner Res 25:20–31
Langston AL, Campbell MK, Fraser WD, Maclennan G, Selby P, Ralston SH (2007) Clinical determinants of quality of life in Paget’s disease of bone. Calcif Tissue Int 80:1–9
Albagha OM, Visconti MR, Alonso N, Wani S, Goodman K, Fraser WD, Gennari L, Merlotti D, Gianfrancesco F, Esposito T, Rendina D, Di Stefano M, Isaia G, Brandi ML, Guisti F, Del Pino-Montes J, Corral-Gudino L, Gonzalez-Sarmiento R, Ward L, Rea SL, Ratajczak T, Walsh JP, Ralston SH (2013) Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget’s disease. J Bone Miner Res 28:2238–2246
Acknowledgments
We thank Mica Petrakis for performing the SQSTM1 mutation screening. This study was supported in part by a grant from Arthritis Research UK (reference 19799).
Conflict of Interest
Stuart H. Ralston reports having received consulting fees on behalf of his institution from Merck and Novartis and research grant funding from Amgen, Arthritis Research UK and the Medical Research Council. Adrian Tan has no conflicts of interest to declare.
Human and Animal Rights and Informed Consent
Ethical approval was not sought for this study since the data presented were collected during the course of routine clinical care. The patients provided consent for their medical records to be reviewed as part of routine care. The study did not involve experimental animals.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tan, A., Ralston, S.H. Clinical Presentation of Paget’s Disease: Evaluation of a Contemporary Cohort and Systematic Review. Calcif Tissue Int 95, 385–392 (2014). https://doi.org/10.1007/s00223-014-9904-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-014-9904-1